• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

M&As this week: Sun Moral International (HK), Immuno Holding

pharmaceutical-technologyMarch 27, 2017

Tag: immuno , M&As

Sun Moral International (HK), a subsidiary of Chinese pharmaceutical company Sihuan Pharmaceutical Holdings Group, has acquired the entire equity interest in Ambest Pharmaceutical (China) Company.

"Immuno Holding’s subsidiary 1111267 B.C has reached an agreement to acquire Immunotec."

The target company is a manufacturer of large-volume injections and was acquired for a consideration of ¥1.1bn ($159.47m).

Immuno Holding’s subsidiary 1111267 B.C has reached an agreement to acquire Immunotec.

The purchase consideration for the acquisition is $0.485 a share.

Based in Canada, the target company develops, manufactures and sells nutritional products.

Previous:Cancer Research UK to support Precision Panc project for pancreatic cancer

Next:Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

M&As this week: Sun Moral International (HK), Immuno Holding | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Human Tetanus Immunoglobulin

Human Tetanus Immunoglobulin
Immunodeficient mice and humanized liver mice

Immunodeficient mice and humanized liver mice
PESP(Prostatic Exosoma Protein)Immunochromatography Rapid Test

PESP(Prostatic Exosoma Protein)Immunochromatography Rapid Test
Human Hepatitis B Immunoglobulin (pH4)

Human Hepatitis B Immunoglobulin (pH4)
Human Immunoglobulin(pH4) for Intravenous Injection

Human Immunoglobulin(pH4) for Intravenous Injection
Immunohistochemical Diagnostic Kit for P185erbB-2/HER-2 Oncoprotein albumin detection

Immunohistochemical Diagnostic Kit for P185erbB-2/HER-2 Oncoprotein albumin detection
Human Rabies Immunoglobulin

Human Rabies Immunoglobulin
Human Rabies Immunoglobulin

Human Rabies Immunoglobulin
Human Immunoglobulin (pH4) for Intravenous Injection

Human Immunoglobulin (pH4) for Intravenous Injection
Human Immunoglobulin (pH4) for Intravenous Injection

Human Immunoglobulin (pH4) for Intravenous Injection

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service